Hepronicate

癸烟酯

Report date: 2022/04/22 08:51:41
NME

Base Information

Drug NameHepronicate
Drug Alias NameMegrin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRaynaud DiseaseThromboangiitis ObliteransArterial Occlusive Diseases +[4] 
Global Approved IndicationsRaynaud DiseaseThromboangiitis ObliteransArterial Occlusive Diseases +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1972/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma CorpYoshitomi Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRaynaud DiseaseThromboangiitis ObliteransArterial Occlusive Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeV03AM
Related LinksKEGG